Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial.
about
Clinical utility of platinum chromium bare-metal stents in coronary heart diseaseClinical outcomes of biodegradable polymer drug-eluting stents for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trialsBiodegradable polymer Biolimus-eluting stent (NoboriĀ®) for the treatment of coronary artery lesions: review of concept and clinical resultsEfficacy and safety of biodegradable polymer biolimus-eluting stents versus durable polymer drug-eluting stents: a meta-analysisSafety and efficacy of biodegradable drug-eluting vs. bare metal stents: a meta-analysis from randomized trialsCan Platforms Affect the Safety and Efficacy of Drug-Eluting Stents in the Era of Biodegradable Polymers?: A Meta-Analysis of 34,850 Randomized IndividualsNew-Generation Coronary Stents: Current Data and Future Directions.Incidence and clinical impact of stent fracture after the Nobori biolimus-eluting stent implantation.A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with CoronarAntiplatelet therapy discontinuation and the risk of serious cardiovascular events after coronary stenting: observations from the CREDO-Kyoto Registry Cohort-2.Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis.Clinical performance of biodegradable versus permanent polymer drug-eluting stents: A meta-analysis of randomized clinical trials at long-term follow-up.Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial.Early endothelialization associated with a biolimus A9 bioresorbable polymer stent in a porcine coronary model.In vivo Evaluation of Cenderitide-Eluting Stent (CES) II.Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE TrialSafety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.Histopathological Comparison among Biolimus, Zotarolimus and Everolimus-Eluting Stents in Porcine Coronary Restenosis Model.STENTING STRATEGY AND FOLLOW-UP RESULTS OF MULTI-CENTER REGISTRY IN FUKUSHIMA CITY FOR LEFT MAIN CORONARY ARTERY DISEASE: BARE METAL STENT VERSUS DRUG-ELUTING STENT.Coronary stents: novel developments.Commentary on late breaking trials in interventional cardiology at ESC, VIVA, TCT, AHA (Fall 2012), and ACC 2013.Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update.The Nobori biolimus-eluting stent: update of available evidence.Drug-eluting stents: the past, present, and future.Biodegradable polymer stents vs second generation drug eluting stents: A meta-analysis and systematic review of randomized controlled trials.Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents.Drug-eluting stents to prevent stent thrombosis and restenosis.Adverse cardiovascular events associated with biodegradable polymer drug-eluting stents and durable polymer everolimus-eluting stents: A systematic review and meta-analysis of 10 randomized controlled trials.Bioresorbable Polymers and Stent Devices.Second-generation versus first-generation drug-eluting stents in patients with and without diabetes mellitus: pooled analysis from the RESET and NEXT trials.Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents.Outcomes of Acute Myocardial Infarction Patients Implanted With Biodegradable Polymer Biolimus-Eluting Stents Versus New-Generation Durable Polymer Drug-Eluting Stents: A Retrospective Analysis.Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome.Long-Term Clinical Outcomes of a Biodegradable Polymer-Based Biolimus-Eluting Stent.Use of bioresorbable vascular scaffold: a meta-analysis of patients with coronary artery disease.Comparison of the safety and efficacy of biodegradable polymer biolimus-eluting stents and durable polymer everolimus-eluting stents: propensity score-matched analysis.Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography.Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness, polymeric carriers and antiproliferative drugs.Favorable outcomes in octogenarians treated with bioresorbable polymer drug-eluting stent.Drug-eluting stent technology: progress beyond the polymer.
P2860
Q26783440-AACBD5A6-7C68-45D2-A5EB-A56B8248C559Q26859403-C204A7ED-BBEB-449F-AEFB-1B72E65427FEQ26864540-2147BEEC-4FF3-427D-B564-2E5EF9A96AC1Q28534994-A1C9BF35-1EAE-4BC5-8426-3E3EBA3CB386Q28539865-5BBDCBC6-9F42-403F-8958-46041EA610E4Q28551120-2F108531-FD9E-4F4C-843D-F6E789000F48Q31164040-C1D2BC4D-5E56-4968-8DB3-5A99CE3B3821Q34297112-A7FBFA33-B7FB-4095-905F-CB1BA29DD983Q34354151-421A72F8-0CD9-47E6-9C0C-8C46A53CC5D5Q35324208-74109D51-A3BE-45B9-8C82-D4D8C04DF2EAQ35495452-76DFB1D9-7D39-45B1-9A44-1FA0503294F5Q35579187-572768FA-F4CC-48B5-A3E3-C929B8EB035FQ36060147-76D477F5-43AE-4321-AF6A-5F534AF7AFE8Q36374512-E30B9D69-B784-421B-AC7C-91E351DD387CQ36470750-10800C17-1B61-4C6C-8B0C-2405C84016F4Q37090890-5C54A522-45EE-4BC6-8353-1226C4FBB9EAQ37284036-EF03F3B6-5957-451A-A4B4-8A91C2FC109AQ37399625-99036E89-FF29-4785-AEC2-E56D508B09A5Q37461045-E3E87F13-C296-4C2E-8337-8C8FC9900FDBQ38134375-00A1A3B5-4F9D-4818-9F8A-6C480DC55C94Q38165916-E37968D6-3C32-4825-97FB-D5DBCC761F18Q38183346-5D5E9464-030B-4824-B208-A4AC49A70060Q38192032-E86E3524-F938-4A21-9924-0E405C0D07C2Q38344198-93762602-A71A-4459-A2B1-1046BBD9C649Q38620880-69753C92-C574-48A6-9FBA-A9341903262BQ38630250-CDB46B67-B2CB-49B1-B9EC-E6D45A04CDD3Q38633332-EA4FD483-DDE9-4003-9879-6D484993A68AQ38682427-F259D35B-953E-4570-9D04-CD17949A12DBQ38919254-61765A93-64F4-46C1-AE89-CC60BA12934BQ38985165-E4E24A0F-B1D2-4052-BA34-79D1ED1F038CQ39053571-9FB41F80-F2EA-43F9-AEBA-A75B222B2A65Q39166453-8CBB4CA8-ED8A-475D-BB57-1C232186A20BQ39632788-CE7FCC8A-80B8-4FF6-BF74-FE0AA440CABBQ39959015-CEDEBC51-CE80-43B3-8E32-325BAF78116DQ41028884-4F06ECE8-3922-4105-B414-419A8BDF3561Q45690043-0A317FF6-B771-40E6-9841-E93D6F479000Q45770520-746E15F6-7638-491C-836D-E0CD3B866F1BQ52334995-B2402532-CD1D-4B5A-9264-55BDE8CFDDD9Q53335552-C035B8F8-AFF1-4957-83D4-CF1CB7BBCF2EQ53531399-BA5E7EB1-903D-422F-8C8F-069D357241DB
P2860
Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial.
description
2013 nĆ® lÅ«n-bĆ»n
@nan
2013幓ć®č«ę
@ja
2013幓č«ę
@yue
2013幓č«ę
@zh-hant
2013幓č«ę
@zh-hk
2013幓č«ę
@zh-mo
2013幓č«ę
@zh-tw
2013幓č®ŗę
@wuu
2013幓č®ŗę
@zh
2013幓č®ŗę
@zh-cn
name
Biodegradable polymer biolimus ...... trolled, noninferiority trial.
@en
Biodegradable polymer biolimus ...... trolled, noninferiority trial.
@nl
type
label
Biodegradable polymer biolimus ...... trolled, noninferiority trial.
@en
Biodegradable polymer biolimus ...... trolled, noninferiority trial.
@nl
prefLabel
Biodegradable polymer biolimus ...... trolled, noninferiority trial.
@en
Biodegradable polymer biolimus ...... trolled, noninferiority trial.
@nl
P2093
P1476
Biodegradable polymer biolimus ...... trolled, noninferiority trial.
@en
P2093
Hideo Nishikawa
Hisayuki Okada
Kazuo Kimura
Kazushi Urasawa
Kazushige Kadota
Keiichi Igarashi
Ken Kozuma
Kengo Tanabe
Masahiro Natsuaki
Masaki Awata
P304
P356
10.1016/J.JACC.2013.04.045
P407
P577
2013-05-15T00:00:00Z